Preclinical investigators at Stark Neurosciences Research Center, led by Xiao-Ming Xu, PhD, study the molecular mechanisms underlying spinal cord injury (SCI) and traumatic brain injury (TBI) to develop novel repair strategies to promote neural reorganization and functional recovery in experimental models of these injuries. The principal goal of these studies is to translate promising treatments from animal models to humans.
Additionally, several faculty conduct behavioral, pharmacological, and neuroimaging research in human pediatric, adolescent and adult TBI. Human research contexts include, but are not restricted to, sports- and combat-related injuries.
